Spheryx awarded Ph II grant to modify tech for biologics industry
Spheryx, Inc. has been awarded a $1.5m grant over two years to support modifications to the company’s propriety protein aggregation detection and monitoring technology.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs